EU Pharmaceutical Regulation: The Politics of Policy-Making
This book provides an analysis of European Union pharmaceutical regulation from a policy-making perspective. The focus is on how the often conflicting agendas of the pharmaceutical industry, the EU member states, the European Commission, and consumer interests are reconciled within the context of regulatory outcomes having to serve public health, healthcare and industrial policy needs within the single market.
Breaking with more traditional approaches which stress the economic determinants of pharmaceutical policy, different strands of public policy analysis, regulatory and European integration and policy-making theories are invoked in developing a new conceptual approach to frame the analysis. In-depth case-studies in three key policy areas: patent protection, market authorisation, and pricing and reimbursement, provide substantive support.
In providing a unique perspective on how and why EU pharmaceutical policy is made, the book will be of interest to academics, students and policy-practitioners interested in EU policy-making, regulation and public policy analysis.
What people are saying - Write a review
We haven't found any reviews in the usual places.
actors agenda application approach approval assessment Association benefits BEUC Brussels case-studies Commission's Committee Community's companies competences competition concerns consumer context costs Council CPMP decisions DGIII discussion drugs economic EFPIA EMEA EMEA's ensure Europe European Commission European Medicines European Medicines Agency European Parliament European Union free movement governments groups harmonisation healthcare policy industrial policy industry's innovation integration interest-group politics interests Internal Market involved ISDB issues legislation maceutical manufacturers market authorisation medicinal products ment parallel trade patent protection patent-term phar pharmaceutical industry pharmaceutical market pharmaceutical policy pharmaceutical regulation pharmaceutical sector policy network policy outcomes policy-making policy-process politics of policy potential price controls pricing and reimbursement priorities products for human promoting proposals public health regime regulatory framework regulatory policy represented research industry result role Single European Market single market specific stakeholders subsidiarity Supplementary Protection Certificate supranational therapeutic tion Transparency Directive